OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/18/2026
Back to search
Official data from USPTO
GRAFALON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GRAFALON
ST13
US500000079414175Class
5, 42, 44
Filing
79414175
Registration
8163972
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/19/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
12/10/2024
Registration date
03/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Neovii Biotech GmbH
Representatives
Patrick F. Clunk Tucker Ellis LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical compositions and preparationspharmaceutical preparations for the treatment of anti-neutrophil cytoplasmic antibody associated vasculitisaplastic anemiaautoimmune diseasesdiabetesfor the prevention and treatment of graft-versus-host diseasehemophagocytic lymphohistiocytosislupus nephritismultiple sclerosismyelodysplastic syndromemyelofibrosissystemic lupus erythematosusas well as for use in organ and tissue transplantation; biopharmaceutical compositions and preparationsin particular those for use in the treatment of immunological conditionstissuestem cell and organ transplantstumors and immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology and hematology; medicinal preparations for use in stem cell transplant procedures; medicinal preparations for use in organ transplant procedures.
Class 42
Scientific services and research for medical purposesnamely medical and scientific research in the field of cell biology and antibodies and immunology; scientific and technological servicesnamely scientific researchanalysistesting in the field of biotechnologybiopharmaceutics and medical science; biotechnological and biopharmaceutical analysesnamely blood analysis services for scientific research purposecell analysis services for scientific research purposeDNA analysis services for scientific research purposehuman leukocyte antigen (HLA) analysis services for scientific research purposeantibodies analysis services for scientific research purposeantigen analysis services for scientific research purposesTechnical research in the field of pharmaceutical studies; medical research laboratory services.
Class 44
Medical services; medicalpharmaceutical and biopharmaceutical services in the nature of medical and pharmaceutical consultation and medical advice and information in the field of oncologyhematologystem cell transplantationorgan transplantation and immunological therapy.
Publications
History of USPTO decisions and trademark events.
26 publications found
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/10/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/31/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/20/2026
PUBO
PUBLISHED FOR OPPOSITION
01/20/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/14/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/18/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/18/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/18/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/24/2025
RFNT
REFUSAL PROCESSED BY IB
08/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/24/2025
RFRR
REFUSAL PROCESSED BY MPU
07/24/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/01/2025
CNRT
NON-FINAL ACTION WRITTEN
05/31/2025
DOCK
ASSIGNED TO EXAMINER
05/28/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/11/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2025
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
01/02/2025
Continuous trademark protection
Get notified about every new filing that threatens GRAFALON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.